Intravenous Immunoglobulin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Intravenous Immunoglobulin Market Size and it is Segmented by Type (IgG, IgA, IgM, IgE, and IgD), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (USD million) for all the above segments.

Intravenous Immunoglobulin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Intravenous Immunoglobulin (IVIG) Industry Overview

The intravenous immunoglobulin market is moderately competitive, and vital global players manufacture most of the intravenous immunoglobulin therapies. Market leaders with more funds for research and a better distribution system have established their positions in the market. The key players in the studied market are Grifols SA, Takeda Pharmaceutical Company Limited, Biotest AG, Bio Products Laboratory Limited, and Kedrion SpA, among others. The major players are involved in strategies such as acquisitions, collaborations, and new product launches to secure their positions in the global market.

Intravenous Immunoglobulin (IVIG) Market Leaders

  1. Biotest AG

  2. Kedrion S.p.A

  3. Grifols, S.A.

  4. Bio Products Laboratory Limited

  5. Takeda Pharmaceutical Company Limited

  6. *Disclaimer: Major Players sorted in no particular order
Intravenous Immunoglobulin Market Concentration

IVIG Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?